Research & KnowledgeEvent: September 1, 2026
Psychedelic Alpha published a Psychedelic Alpha Bulletin featuring developments on psychedelic drug development, policy, and access, including Deborah Mash, the researcher behind the ibogaine IND, stating she has no knowledge of the reported gift.
Published
Signal category
Research & Knowledge
Quote
“Deborah Mash, the researcher behind that IND, told me that she has no knowledge of this reported gift.”
— Josh Hardman|Psychedelic Alpha team
Company
Psychedelic Alpha
The leading independent, data-driven voice in psychedelics.
- Industry
- Business Consulting and Services
- Location
- London, GB
- Company size
- 5 employees
The definitive resource for analysis of the emergent psychedelic medicine sector. Cut through the noise with exclusive news, interviews, data and opportunities.
Founded 2020